Fig. 3From: Significant response to atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma with major portal vein tumor thrombus: a case reportTransition of the serum alfa-fetoprotein level during the treatment course. AFP, alfa-fetoprotein; Ate/bev, atezolizumab plus bevacizumab treatment; Ate, atezolizumab treatmentBack to article page